USCA RIA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$2.29M Buy
18,484
+3,246
+21% +$408K 0.14% 198
2021
Q1
$1.8M Sell
15,238
-76
-0.5% -$8.91K 0.12% 226
2020
Q4
$1.79M Buy
15,314
+1,322
+9% +$146K 0.13% 167
2020
Q3
$1.45M Sell
13,992
-13,361
-49% -$1.34M 0.11% 171
2020
Q2
$2.51M Sell
27,353
-13,101
-32% -$1.26M 0.22% 99
2020
Q1
$3.65M Sell
40,454
-4,796
-11% -$510K 0.42% 55
2019
Q4
$5.13M Buy
45,250
+11,575
+34% +$1.27M 0.46% 63
2019
Q3
$3.66M Sell
33,675
-1,809
-5% -$189K 0.36% 83
2019
Q2
$3.46M Buy
35,484
+215
+0.6% +$19.6K 0.35% 86
2019
Q1
$3.21M Sell
35,269
-1,984
-5% -$178K 0.35% 98
2018
Q4
$3.39M Sell
37,253
-4,064
-10% -$380K 0.45% 64
2018
Q3
$4.06M Buy
41,317
+121
+0.3% +$11.2K 0.41% 63
2018
Q2
$3.53M Sell
41,196
-1,096
-3% -$91.5K 0.38% 72
2018
Q1
$3.39M Buy
42,292
+3,438
+9% +$284K 0.37% 74
2017
Q4
$3.14M Buy
38,854
+2,136
+6% +$171K 0.35% 88
2017
Q3
$3.26M Hold
36,718
0.42% 69
2017
Q2
$3.26M Sell
36,718
-472
-1% -$39.8K 0.42% 70
2017
Q1
$3M Buy
37,190
+26,247
+240% +$2.05M 0.44% 57
2016
Q4
$779K Buy
10,943
+100
+0.9% +$7.86K 0.12% 196
2016
Q3
$937K Buy
10,843
+45
+0.4% +$3.92K 0.16% 166
2016
Q2
$937K Sell
10,798
-200
-2% -$16.2K 0.16% 163
2016
Q1
$825K Buy
10,998
+1,280
+13% +$96.4K 0.15% 162
2015
Q4
$748K Sell
9,718
-200
-2% -$15.1K 0.16% 167
2015
Q3
$664K Hold
9,918
0.17% 160
2015
Q2
$735K Buy
9,918
+157
+2% +$12K 0.19% 146
2015
Q1
$761K Sell
9,761
-15,087
-61% -$1.14M 0.2% 136
2014
Q4
$1.79M Sell
24,848
-1,861
-7% -$129K 0.5% 50
2014
Q3
$1.66M Buy
26,709
+1,259
+5% +$80K 0.5% 53
2014
Q2
$1.62M Buy
25,450
+2,282
+10% +$139K 0.54% 46
2014
Q1
$1.43M Buy
23,168
+1,599
+7% +$93.1K 0.51% 53
2013
Q4
$1.24M Buy
21,569
+12,162
+129% +$690K 0.49% 56
2013
Q3
$501K Sell
9,407
-200
-2% -$10.8K 0.23% 119
2013
Q2
$494K Buy
+9,607
New +$475K 0.25% 116

Other funds holding MDT

USCA RIA's MDT Position: Q2 2021 in Review

USCA RIA increased its Medtronic (MDT) stake by 21% in Q2 2021, buying an estimated $408K and bringing the position to 18,484 shares worth $2.29M. The position accounts for 0.14% of the portfolio, ranked #198.

USCA RIA first reported a position in MDT in Q2 2013 and has held it in 33 quarters since. The position peaked at $5.13M in Q4 2019. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • USCA RIA held 18,484 shares of Medtronic worth $2.29M as of Q2 2021.
  • USCA RIA bought 3,246 Medtronic shares in Q2 2021, an estimated $408K.
  • Medtronic made up 0.14% of USCA RIA's portfolio in Q2 2021, its #198 holding.
  • USCA RIA first reported a position in Medtronic in Q2 2013 and has held it in 33 quarters since.
  • USCA RIA's Medtronic position peaked at $5.13M in Q4 2019.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.